![James Lulo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James Lulo
Corporate Officer/Principal chez Rapid Pathogen Screening, Inc.
Postes actifs de James Lulo
Sociétés | Poste | Début | Fin |
---|---|---|---|
Rapid Pathogen Screening, Inc.
![]() Rapid Pathogen Screening, Inc. Medical/Nursing ServicesHealth Services Rapid Pathogen Screening, Inc. is an emerging biotechnology company strategically focused on designing, developing, and delivering novel point-of-care tests for infectious diseases and inflammatory conditions as well as bio-terrorism and chemical nerve agent blood toxins. The firm’s products include AdenoPlus, InflammaDry, FebriDx. The company was founded by Robert P. Sambursky and Robert W. VanDine in 2004 and is headquartered in Sarasota, FL. | Corporate Officer/Principal | - | - |
Historique de carrière de James Lulo
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Corporate Officer/Principal | 1 |
Sectorielle
Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Rapid Pathogen Screening, Inc.
![]() Rapid Pathogen Screening, Inc. Medical/Nursing ServicesHealth Services Rapid Pathogen Screening, Inc. is an emerging biotechnology company strategically focused on designing, developing, and delivering novel point-of-care tests for infectious diseases and inflammatory conditions as well as bio-terrorism and chemical nerve agent blood toxins. The firm’s products include AdenoPlus, InflammaDry, FebriDx. The company was founded by Robert P. Sambursky and Robert W. VanDine in 2004 and is headquartered in Sarasota, FL. | Health Services |
- Bourse
- Insiders
- James Lulo
- Expérience